Crawford & Company (CRD-B) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Crawford & Company $3.49, price $12.04, upside -71.0%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Crawford & Company for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range $4.55 – $13.10 · fair‑value band $3.13 – $4.23 · the $12.04 price screens above the $3.49 fair value. Dashed = 300-day average. As of Oct 2, 2026.
Follow Crawford & in your weekly email
Every Wednesday you see whether Crawford & is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America.
Show more
Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The company provides claims management services to insurance carriers and self-insured entities risk, including property, public liability, automobile liability, and marine insurance; claims management and adjusting services to insurance carriers and self-insured entities from property and casualty insurance company markets; and field investigation and the evaluation and resolution of property and casualty insurance claims. It also offers claims management services, including workers' compensation, liability, and property; death and dismemberment, business travel, life, disability, critical illness, and credit protection claims programs; short and long term disability, family medical leave act, Americans with disabilities act, and state leave claims; legal services, risk management information, and consultative analytical services; loss mitigation services, such as medical bill review, medical case management and vocational rehabilitation; risk management information services; and administration of loss funds established to pay claims. In addition, the company provides managed repair service and outsourced contractor management to national and regional personal and commercial insurance carriers; services to insurance companies on losses caused by all types of natural disasters comprising fires, hailstorms, hurricanes, earthquakes, floods, as well as man-made disasters, such as oil spills, chemical releases, and explosions; staff augmentation that provides temporary staffing resources; and outsourced subrogation claims management, recovery, and consultative services for the property and casualty insurance industry. Crawford & Company was founded in 1941 and is headquartered in Atlanta, Georgia.
Stock analysis
Crawford & Company (CRD-B) currently trades at $12.04, while our model-based Fair Value estimate is $3.49, 71.0% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $4.95 per share, and 0 of the 6 models we run sit above the $12.04 price.
Bear case: the Asset-Based group reads lowest at $2.37, and 6 of the 6 models stay below the price. Evidence for this calculation is high.
Scenario range: $3.13 (bear) to $4.23 (bull), the price of $12.04 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 63/100 (solid quality), in the Financial Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Crawford & Company reported revenue of $1.3B in FY2025 versus $1.1B in FY2021, a compound +3.6%/yr. Reported net income was $19.6M in FY2025, compounding −10.6%/yr from FY2021.
Key figures
Market cap $590M · P/E ratio 26.5 · P/S ratio 0.40 · EPS (TTM) $0.4700 · Dividend yield 2.5% · Net margin 1.5% · Return on equity 13.0% · Return on assets (EBIT) 7.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (medium confidence).
What moves the price
The share trades about 8% below its 52-week high and 34% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −54% fair-value upside, at −71%, CRD-B screens richer than that median.
Fair Value models
Bear $3.13Fair Value $3.49Bull $4.23
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.1285 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.64/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−2.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.3%
Start year 2020 (pandemic). Over 10 years: +0.6% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−3.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.8%
Dividend (yield on the price)2.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−5.8% vs −4.5%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 6%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−7.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+1.6%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −9.5% a year for the price and −0.7% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance Brokers · 37 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score60 · Below median
Fair Value upside−70.9% · Bottom 25%
Profitability
Return on equity (TTM)13.0% · Below median
Return on assets5.1% · Above median
Net margin (TTM)1.9% · Bottom 25%
Operating margin (TTM)7.4% · Below median
Growth and dividend
Revenue growth−0.5% · Bottom 25%
Dividend yield (TTM)2.5% · Below median
Balance sheet
Debt / equity0.87× · Highest 25%
Valuation Multiplesvs Insurance Brokers median · lower = cheaper
P/E (TTM)26.5× · Pricier than median
P/B3.40× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)0.47× · Cheapest 25%
P/FCF6.2× · Cheapest 25%
EV/EBITDA8.5× · Cheaper than median
PEG0.90× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 54
PAST (return on equity)52· sector 60
HEALTH (low debt)57· sector 84
DIVIDEND (yield)50· sector 94
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Crawford & Company Fair Value". https://www.fairvalue-calculator.com/stock/CRD-B
Frequently asked questions
Is Crawford & Company (CRD-B) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of $3.49 versus a price of $12.04, about −71% upside (overvalued).
What is the fair value of CRD-B?
Our model-based fair value for Crawford & Company is $3.49 (as of Oct 2, 2026), built from audited fundamentals. The current price: $12.04.
What is the quality score of CRD-B?
Crawford & Company has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Crawford & Company (CRD-B)?
Our model-based price target is the fair value of $3.49 (as of Oct 2, 2026) from 6 valuation models. Cautious scenario $3.13, optimistic scenario $4.23. It is a calculation from audited fundamentals, not an analyst target.
What is the Crawford & Company stock forecast for 2026?
Our models put fair value at $3.49, about −71% upside versus a price of $12.04 (overvalued). Cautious scenario $3.13, optimistic scenario $4.23. The calculation is refreshed regularly with new filings.
What is the revenue of Crawford & Company (CRD-B)?
Crawford & Company reported trailing-twelve-month revenue of about $1.3B (latest available figure, as of Oct 2, 2026).
Does Crawford & Company pay a dividend?
Crawford & Company currently shows a dividend yield of about 2.49% relative to its recent price (as of Oct 2, 2026).
What growth is priced into Crawford & Company (CRD-B)?
For today's price to be fair in a discounted-cash-flow model, Crawford & Company would have to grow free cash flow by -7.3 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.3 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of CRD-B use?
Our models discount Crawford & Company at 10.1 %: a base by market capitalisation (small), damped by beta 0.60, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Crawford & Company that is -7.3 % per year a year over ten years, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Crawford & Company (CRD-B) delivered so far?
Over the past 5 years revenue at Crawford & Company grew +5.3 % a year. The price currently implies -7.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Crawford & Company (CRD-B) growing?
The median revenue growth in the sector is +9.2 % a year. That is the yardstick for the growth priced into Crawford & Company (-7.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Crawford & Company (CRD-B)?
The free-cash-flow yield on the price is 16.08 %: that much free cash flow Crawford & Company produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Crawford & Company (CRD-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Crawford & Company it is $3.49 per share (as of Oct 2, 2026), against a price of $12.04. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is Crawford & Company stock overvalued or undervalued in 2026?
As of Oct 2, 2026, CRD-B trades above its calculated fair value: price $12.04, fair value $3.49, a gap of about −71% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CRD-B?
No. The price is what the market pays today ($12.04); the fair value is what the company's own numbers justify ($3.49). For Crawford & Company the two are $8.55 per share apart. That gap is exactly why we show both numbers side by side.
How much is Crawford & Company worth?
The market values Crawford & Company at about $590M (market capitalisation, as of Oct 2, 2026). Per share that is $12.04; our models calculate a fair value of $3.49 per share.
What do the bullish and bearish scenarios say about CRD-B?
Our models span a range for Crawford & Company: cautious scenario $3.13, base $3.49, optimistic $4.23 per share (as of Oct 2, 2026, price $12.04). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CRD-B?
Crawford & Company trades at a price-to-earnings ratio of 26.5 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $3.49 is built from several models across several years. Excluding one-off items of fiscal year 2025 it is 13.2 (reported for FY2025: 30.7). Other multiples: PEG 0.9, P/B 3.4, P/S 0.5, EV/EBITDA 8.5.
What is the PEG ratio of CRD-B?
The PEG ratio of Crawford & Company is 0.90 (P/E divided by earnings growth, as of Oct 2, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Crawford & Company (CRD-B)?
Balance-sheet figures for Crawford & Company (as of Oct 2, 2026): return on equity 13.0%, debt of 0.87 per unit of equity. They feed the Quality Score of 63/100, which measures business quality independently of the share price.
How far is CRD-B from its 52-week high?
Crawford & Company trades at $12.04, about 8% below its 52-week high of $13.10 and 34% above the low of $8.95 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $3.49 is for.
Which stocks are comparable to Crawford & Company?
From the same area (Financial Services) we also value Marsh & McLennan Companies, Inc, Arthur J. Gallagher & Co, Aon plc, Willis Towers Watson Public Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Crawford & Company stock attractive at the current price?
The data as of Oct 2, 2026: price $12.04, calculated fair value $3.49 (−71%), Quality Score 63/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CRD-B calculated?
We run Crawford & Company through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $3.49, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Crawford & Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Crawford & Company (CRD-B)?
The closing price on Oct 2, 2026 was $12.04. Our model-based fair value is $3.49, about −71% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Crawford & Company right now?
The price sits above even our optimistic bull case ($4.23). The favourable scenario is already priced in. Solid but not exceptional quality (63/100) and above fair value, neither a clear bargain nor a standout compounder. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of Crawford & Company (CRD-B) come from?
Earnings per share at Crawford & Company grew −2.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +2.0 %, EBIT margin −1.2 %, tax rate +1.4 %, residual (interest, one-offs) −4.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Crawford & Company
How large is the market capitalisation of Crawford & Company (CRD-B)?
The market capitalisation of Crawford & Company is $590M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Crawford & Company (CRD-B)?
The price-to-sales ratio of Crawford & Company is 0.40 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Crawford & Company (CRD-B)?
Earnings per share at Crawford & Company are $0.4700 (price ÷ EPS = P/E 26.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Crawford & Company (CRD-B)?
The dividend yield of Crawford & Company is 2.5% (payout 27.5%, on adjusted earnings, reported 63.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Crawford & Company (CRD-B)?
The net margin of Crawford & Company is 1.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Crawford & Company (CRD-B)?
The return on equity (ROE) of Crawford & Company is 13.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Crawford & Company (CRD-B)?
On an EBIT basis the return on assets of Crawford & Company is 7.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Crawford & Company (CRD-B)?
The operating margin of Crawford & Company is 7.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Crawford & Company (CRD-B)?
Revenue at Crawford & Company is growing −0.5% versus a year earlier (3y avg +2.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Crawford & Company (CRD-B)?
Earnings per share at Crawford & Company are growing +76.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Crawford & Company (CRD-B) carry?
The net debt of Crawford & Company is $206M (fiscal year 2025, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Crawford & Company in the live analysis
One click puts Crawford & Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Broad data
Oct 2, 2026